These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 14764682)
1. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen. van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682 [TBL] [Abstract][Full Text] [Related]
2. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049 [TBL] [Abstract][Full Text] [Related]
3. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive. Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556 [TBL] [Abstract][Full Text] [Related]
4. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. Nicolls MR; Coulombe M; Beilke J; Gelhaus HC; Gill RG J Immunol; 2002 Nov; 169(9):4831-9. PubMed ID: 12391193 [TBL] [Abstract][Full Text] [Related]
5. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. Ito H; Kurtz J; Shaffer J; Sykes M J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246 [TBL] [Abstract][Full Text] [Related]
6. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. van Maurik Av; Herber M; Wood KJ; Jones ND J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913 [TBL] [Abstract][Full Text] [Related]
7. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555 [TBL] [Abstract][Full Text] [Related]
8. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. Chen Y; Heeger PS; Valujskikh A J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287 [TBL] [Abstract][Full Text] [Related]
9. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation. Zhai Y; Shen XD; Gao F; Coito AJ; Wasowska BA; Salama A; Schmitt I; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW J Immunol; 2002 Aug; 169(3):1270-6. PubMed ID: 12133948 [TBL] [Abstract][Full Text] [Related]
10. Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation. Reed AJ; Noorchashm H; Rostami SY; Zarrabi Y; Perate AR; Jeganathan AN; Caton AJ; Naji A J Immunol; 2003 Dec; 171(12):6502-9. PubMed ID: 14662850 [TBL] [Abstract][Full Text] [Related]
11. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo. Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857 [TBL] [Abstract][Full Text] [Related]
13. Costimulatory blockade induces hyporesponsiveness in T cells that recognize alloantigen via indirect antigen presentation. Phillips NE; Greiner DL; Mordes JP; Rossini AA Transplantation; 2006 Oct; 82(8):1085-92. PubMed ID: 17060858 [TBL] [Abstract][Full Text] [Related]
14. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms. Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665 [TBL] [Abstract][Full Text] [Related]
15. Contribution of CD40-CD154-mediated costimulation to an alloresponse in vivo. Förster E; Krenger W; Joergensen J; Hof R; Geha RS; Holländer GA Transplantation; 1999 May; 67(9):1284-7. PubMed ID: 10342324 [TBL] [Abstract][Full Text] [Related]
16. Skin allograft maintenance in a new synchimeric model system of tolerance. Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833 [TBL] [Abstract][Full Text] [Related]
17. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407 [TBL] [Abstract][Full Text] [Related]
18. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis. Yen MH; Lepak N; Swain SL J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374 [TBL] [Abstract][Full Text] [Related]
19. Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Xu H; Yan J; Huang Y; Chilton PM; Ding C; Schanie CL; Wang L; Ildstad ST Blood; 2008 Mar; 111(6):3266-75. PubMed ID: 17827394 [TBL] [Abstract][Full Text] [Related]
20. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]